FibroBiologics (FBLG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.97, -2.90% vs the prior close of $1.00.
- Volume 35.97K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FBLG dips 2.9% to $0.97. Closed at $0.97, -2.90% vs the prior close of $1.00. Day range $0.95–$1.04, opened at $1.02.
FBLG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — FBLG dips 2.9% to $0.97
- Closed at $0.97, -2.90% vs the prior close of $1.00. Day range $0.95–$1.04, opened at $1.02.
- Volume was 35.97K shares, 0.2x its 50-day average of 237.71K — lighter than usual.
- Price is -27.3% vs its 50-day average ($1.33) and -63.1% vs its 200-day average ($2.63).
- 52-week range $0.62–$9.60; today's close sits at 4% of that range, 89.9% below the 52-week high.
Oct 15, 2026 — FBLG jumps 5.3% to $1.00
- Closed at $1.00, +5.26% vs the prior close of $0.95. Day range $0.96–$1.05, opened at $0.96.
- Volume was 156.20K shares, 0.7x its 50-day average of 237.88K.
- Price is -25.1% vs its 50-day average ($1.34) and -62.3% vs its 200-day average ($2.65).
- 52-week range $0.62–$9.66; today's close sits at 4% of that range, 89.6% below the 52-week high.
Oct 14, 2026 — FBLG dips 1.0% to $0.95, a 1-month low, 3 down days in a row
- Closed at $0.95, -1.04% vs the prior close of $0.96. Day range $0.93–$1.02, opened at $1.00.
- Volume was 109.10K shares, 0.5x its 50-day average of 238.56K — lighter than usual.
- Price is -28.7% vs its 50-day average ($1.33) and -64.5% vs its 200-day average ($2.67).
- 52-week range $0.62–$9.66; today's close sits at 4% of that range, 90.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — FBLG slides 4.0% to $0.96, a 1-month low
- Closed at $0.96, -4.00% vs the prior close of $1.00. Day range $0.93–$1.02, opened at $1.00.
- Volume was 80.60K shares, 0.3x its 50-day average of 242.21K — lighter than usual.
- Price is -27.8% vs its 50-day average ($1.33) and -64.4% vs its 200-day average ($2.69).
- 52-week range $0.62–$9.66; today's close sits at 4% of that range, 90.1% below the 52-week high.
Oct 12, 2026 — FBLG slides 11.5% to $1.00, a 1-month low
- Closed at $1.00, -11.50% vs the prior close of $1.13. Day range $0.99–$1.13, opened at $1.12.
- Volume was 152.00K shares, 0.6x its 50-day average of 241.40K.
- Price is -24.6% vs its 50-day average ($1.33) and -63.1% vs its 200-day average ($2.71).
- 52-week range $0.62–$9.98; today's close sits at 4% of that range, 90.0% below the 52-week high.
Oct 9, 2026 — FBLG rises 1.8% to $1.13
- Closed at $1.13, +1.80% vs the prior close of $1.11. Day range $1.10–$1.20, opened at $1.11.
- Volume was 182.30K shares, 0.8x its 50-day average of 240.32K.
- Price is -14.5% vs its 50-day average ($1.32) and -58.7% vs its 200-day average ($2.73).
- 52-week range $0.62–$10.28; today's close sits at 5% of that range, 89.0% below the 52-week high.
Oct 8, 2026 — FBLG dips 2.6% to $1.11, a 1-month low
- Closed at $1.11, -2.63% vs the prior close of $1.14. Day range $1.05–$1.14, opened at $1.12.
- Volume was 71.90K shares, 0.3x its 50-day average of 240.56K — lighter than usual.
- Price is -15.5% vs its 50-day average ($1.31) and -59.7% vs its 200-day average ($2.75).
- 52-week range $0.62–$10.34; today's close sits at 5% of that range, 89.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 7, 2026 — FBLG rises 0.9% to $1.14
- Closed at $1.14, +0.88% vs the prior close of $1.13. Day range $1.07–$1.20, opened at $1.16.
- Volume was 233.80K shares, 1.0x its 50-day average of 237.17K.
- Price is -12.6% vs its 50-day average ($1.30) and -58.9% vs its 200-day average ($2.77).
- 52-week range $0.62–$11.40; today's close sits at 5% of that range, 90.0% below the 52-week high.
Oct 6, 2026 — FBLG slides 4.2% to $1.13, a 1-month low
- Closed at $1.13, -4.24% vs the prior close of $1.18. Day range $1.12–$1.23, opened at $1.20.
- Volume was 210.30K shares, 0.9x its 50-day average of 236.23K.
- Price is -12.7% vs its 50-day average ($1.29) and -59.6% vs its 200-day average ($2.79).
- 52-week range $0.62–$11.40; today's close sits at 5% of that range, 90.1% below the 52-week high.
Oct 5, 2026 — FBLG slides 4.8% to $1.18, a 1-month low
- Closed at $1.18, -4.84% vs the prior close of $1.24. Day range $1.18–$1.24, opened at $1.24.
- Volume was 94.10K shares, 0.4x its 50-day average of 235.39K — lighter than usual.
- Price is -8.1% vs its 50-day average ($1.28) and -58.1% vs its 200-day average ($2.82).
- 52-week range $0.62–$11.40; today's close sits at 5% of that range, 89.6% below the 52-week high.
Oct 2, 2026 — FBLG rises 2.9% to $1.24
- Closed at $1.24, +2.90% vs the prior close of $1.21. Day range $1.10–$1.24, opened at $1.20.
- Volume was 148.60K shares, 0.6x its 50-day average of 233.35K.
- Price is -2.7% vs its 50-day average ($1.27) and -56.2% vs its 200-day average ($2.83).
- 52-week range $0.62–$11.40; today's close sits at 6% of that range, 89.1% below the 52-week high.
FBLG latest news & SEC filings
Every SEC filing by or about FBLG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form POS AM — POS AM filing
POS AM filing
Oct 13, 2026 · Form POS AM — POS AM filing
POS AM filing
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 17, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 9, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 1, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.12M (prior year -$4.66M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.66 (prior year -$2.41) (loss narrowed vs Jun 30, 2025)
Jul 31, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade FBLG
- How much it moves: over the last 20 sessions the average daily move was 3.37% (largest 11.5%). That is a volatile stock.
- Liquidity: about 138.47K shares (≈$134.46K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.97 vs a range of $0.62–$9.60 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Mar 30, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Hamid Khoja bought 30,000 shares on Mar 4, 2026.
- Latest filings: 8-K Oct 8, 2026; 8-K Sep 18, 2026; 8-K Sep 15, 2026.
- Share count: 6.66M shares outstanding (Jul 31, 2026), -84.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
FBLG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.02 | 1.04 | 0.95 | 0.97 | 35.97K |
| Oct 15, 2026 | 0.96 | 1.05 | 0.96 | 1.00 | 156.20K |
| Oct 14, 2026 | 1.00 | 1.02 | 0.93 | 0.95 | 109.10K |
| Oct 13, 2026 | 1.00 | 1.02 | 0.93 | 0.96 | 80.60K |
| Oct 12, 2026 | 1.12 | 1.13 | 0.99 | 1.00 | 152.00K |
| Oct 9, 2026 | 1.11 | 1.20 | 1.10 | 1.13 | 182.30K |
| Oct 8, 2026 | 1.12 | 1.14 | 1.05 | 1.11 | 71.90K |
| Oct 7, 2026 | 1.16 | 1.20 | 1.07 | 1.14 | 233.80K |
| Oct 6, 2026 | 1.20 | 1.23 | 1.12 | 1.13 | 210.30K |
| Oct 5, 2026 | 1.24 | 1.24 | 1.18 | 1.18 | 94.10K |
| Oct 2, 2026 | 1.20 | 1.24 | 1.10 | 1.24 | 148.60K |
| Oct 1, 2026 | 1.32 | 1.32 | 1.16 | 1.21 | 140.10K |
| Sep 30, 2026 | 1.35 | 1.40 | 1.28 | 1.30 | 107.30K |
| Sep 29, 2026 | 1.38 | 1.41 | 1.26 | 1.31 | 191.80K |
| Sep 28, 2026 | 1.44 | 1.48 | 1.34 | 1.36 | 241.60K |
| Sep 25, 2026 | 1.35 | 1.39 | 1.33 | 1.39 | 55.40K |
| Sep 24, 2026 | 1.35 | 1.47 | 1.33 | 1.36 | 258.60K |
| Sep 23, 2026 | 1.32 | 1.45 | 1.31 | 1.33 | 87.30K |
| Sep 22, 2026 | 1.35 | 1.41 | 1.33 | 1.34 | 95.80K |
| Sep 21, 2026 | 1.46 | 1.46 | 1.29 | 1.36 | 116.70K |
About FibroBiologics
FibroBiologics (FBLG) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HOUSTON, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1958777.
FBLG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Richard C. Jr. Cilento | Director | Jun 23, 2026 |
| Robert E. Hoffman | Director | Jun 23, 2026 |
| Matthew Link | Director | Jun 23, 2026 |
| Victoria Ninon Olivia Niklas | Director | Jun 23, 2026 |
| Pete O'Heeron | CHIEF EXECUTIVE OFFICER | May 4, 2026 |
| Kathleen Hallisey Rubins | Director | Jul 16, 2026 |
| Leigh Steinberg | Director | Sep 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jason Davis | Chief Financial Officer | May 4, 2026 |
| Ruben A Garcia | General Counsel | May 4, 2026 |
| Hamid Khoja | Chief Scientific Officer | Sep 15, 2026 |
| Pete O'Heeron | CHIEF EXECUTIVE OFFICER | May 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 4, 2026 | Hamid Khoja | Buy | 30,000 | $0.38 |
| Mar 4, 2026 | Hamid Khoja | Buy | 30,000 | $0.38 |
| Mar 4, 2026 | Hamid Khoja | Buy | 30,000 | $0.38 |
| Mar 4, 2026 | Hamid Khoja | Buy | 30,000 | $0.38 |
| Mar 4, 2026 | Pete O'Heeron | Buy | 15,872 | $0.38 |
| Mar 4, 2026 | Pete O'Heeron | Buy | 15,872 | $0.38 |
| Mar 4, 2026 | Pete O'Heeron | Buy | 15,872 | $0.38 |
| Mar 4, 2026 | Pete O'Heeron | Buy | 15,872 | $0.38 |
| Mar 3, 2026 | Pete O'Heeron | Buy | 18,200 | $0.41 |
| Mar 3, 2026 | Pete O'Heeron | Buy | 18,200 | $0.41 |
| Mar 3, 2026 | Pete O'Heeron | Buy | 18,200 | $0.41 |
| Mar 3, 2026 | Pete O'Heeron | Buy | 18,200 | $0.41 |
| Mar 2, 2026 | Pete O'Heeron | Buy | 17,428 | $0.35 |
| Mar 2, 2026 | Pete O'Heeron | Buy | 17,428 | $0.35 |
| Mar 2, 2026 | Pete O'Heeron | Buy | 17,428 | $0.35 |
FBLG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-18.65M | -0.42 | $-16.39M |
| Dec 31, 2024 | — | $-11.16M | -0.34 | $-11.90M |
| Dec 31, 2023 | — | $-16.48M | -0.68 | $-6.40M |
| Dec 31, 2022 | — | $-5.12M | -0.18 | $-4.07M |
Latest balance sheet: total assets $7.93M, total liabilities $3.29M, cash $3.52M (as of Jun 30, 2026).
FBLG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on FBLG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.